The role of soluble urokinase plasminogen activator receptor (suPAR) in patients with cancer: a review of the current literature.
Paraskevas T, Mulita F, Michailides C, Verras GI, Liolis E, Oikonomou E, Perdikaris I, Perdikaris P, Bouchagier K, Panagiotopoulos I, Kasartzian DI, Filis D, Tchabashvili L, Spyropoulou D, Velissaris D.
Paraskevas T, et al. Among authors: perdikaris p, perdikaris i.
Med Glas (Zenica). 2022 Aug 1;19(2). doi: 10.17392/1456-22. Online ahead of print.
Med Glas (Zenica). 2022.
PMID: 35924801
Free article.